Panel

panel atypical HUS (CFH, CFI, CFB, C3, MCP (CD46), MLPA CFH operon)

Turnaround time
8 weeks
Performing laboratory
Radboudumc
€ 1500

panel atypical HUS (CFH, CFI, CFB, C3, MCP (CD46), MLPA CFH operon)



€ 1500

panel atypical HUS (CFH, CFI, CFB, C3, MCP (CD46), MLPA CFH operon)

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Atypical Hemolytic Uremic Syndrome (aHUS)
  • Conditions > Renal / Nephrological > Atypical Hemolytic Uremic Syndrome (aHUS)

Turnaround time
8 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA




€ 1500
Panel

panel atypical HUS (CFHR1, CFHR2, CFHR3, CFHR4, CFHR5, THBD, DGKE)

Turnaround time
8 weeks
Performing laboratory
Radboudumc
€ 1150

panel atypical HUS (CFHR1, CFHR2, CFHR3, CFHR4, CFHR5, THBD, DGKE)



€ 1150

panel atypical HUS (CFHR1, CFHR2, CFHR3, CFHR4, CFHR5, THBD, DGKE)

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Atypical Hemolytic Uremic Syndrome (aHUS)
  • Conditions > Renal / Nephrological > Atypical Hemolytic Uremic Syndrome (aHUS)

Turnaround time
8 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA




€ 1150
Gene

C3 - atypical hemolytic uremic syndrome (aHUS)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

C3 - atypical hemolytic uremic syndrome (aHUS)



€ 725

C3 - atypical hemolytic uremic syndrome (aHUS)

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Atypical Hemolytic Uremic Syndrome (aHUS)
  • Conditions > Renal / Nephrological > Atypical Hemolytic Uremic Syndrome (aHUS)

This product is also part of the following panels:

  • WES hemostatic/thrombotic disorders (99.4% **)
  • WES Mendelian inherited disorders (99.4% **)
  • WES primary immunodeficiencies (99.4% **)
  • WES renal disorders (99.4% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 120700
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725
Gene

CFB - atypical hemolytic uremic syndrome (aHUS)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

CFB - atypical hemolytic uremic syndrome (aHUS)



€ 725

CFB - atypical hemolytic uremic syndrome (aHUS)

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Atypical Hemolytic Uremic Syndrome (aHUS)
  • Conditions > Renal / Nephrological > Atypical Hemolytic Uremic Syndrome (aHUS)

This product is also part of the following panels:

  • WES hemostatic/thrombotic disorders (99.9% **)
  • WES Mendelian inherited disorders (99.9% **)
  • WES primary immunodeficiencies (99.9% **)
  • WES renal disorders (99.9% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 138470
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725
Gene

CFH - atypical hemolytic uremic syndrome (aHUS)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

CFH - atypical hemolytic uremic syndrome (aHUS)



€ 725

CFH - atypical hemolytic uremic syndrome (aHUS)

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Atypical Hemolytic Uremic Syndrome (aHUS)
  • Conditions > Renal / Nephrological > Atypical Hemolytic Uremic Syndrome (aHUS)

This product is often ordered in combination with:

This product is also part of the following panels:

  • WES hemostatic/thrombotic disorders (97.9% **)
  • WES Mendelian inherited disorders (97.9% **)
  • WES primary immunodeficiencies (97.9% **)
  • WES renal disorders (97.9% **)
  • WES vision disorders (97.9% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 134370
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725
Gene

CFHR1 - atypical hemolytic uremic syndrome (aHUS)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

CFHR1 - atypical hemolytic uremic syndrome (aHUS)



€ 725

CFHR1 - atypical hemolytic uremic syndrome (aHUS)

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Atypical Hemolytic Uremic Syndrome (aHUS)
  • Conditions > Renal / Nephrological > Atypical Hemolytic Uremic Syndrome (aHUS)

This product is also part of the following panels:

  • WES hemostatic/thrombotic disorders (90.8% **)
  • WES primary immunodeficiencies (90.8% **)
  • WES renal disorders (90.8% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 134371
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725
Gene

CFHR2 - atypical hemolytic uremic syndrome (aHUS)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

CFHR2 - atypical hemolytic uremic syndrome (aHUS)



€ 725

CFHR2 - atypical hemolytic uremic syndrome (aHUS)

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Atypical Hemolytic Uremic Syndrome (aHUS)
  • Conditions > Renal / Nephrological > Atypical Hemolytic Uremic Syndrome (aHUS)

This product is also part of the following panels:

  • WES primary immunodeficiencies (96.8% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 600889
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725
Gene

CFHR3 - atypical hemolytic uremic syndrome (aHUS)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

CFHR3 - atypical hemolytic uremic syndrome (aHUS)



€ 725

CFHR3 - atypical hemolytic uremic syndrome (aHUS)

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Atypical Hemolytic Uremic Syndrome (aHUS)
  • Conditions > Renal / Nephrological > Atypical Hemolytic Uremic Syndrome (aHUS)

This product is also part of the following panels:

  • WES hemostatic/thrombotic disorders (91.6% **)
  • WES primary immunodeficiencies (91.6% **)
  • WES renal disorders (91.6% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 605336
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725
Gene

CFHR4 - atypical hemolytic uremic syndrome (aHUS)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

CFHR4 - atypical hemolytic uremic syndrome (aHUS)



€ 725

CFHR4 - atypical hemolytic uremic syndrome (aHUS)

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Atypical Hemolytic Uremic Syndrome (aHUS)
  • Conditions > Renal / Nephrological > Atypical Hemolytic Uremic Syndrome (aHUS)

This product is also part of the following panels:

  • WES primary immunodeficiencies (99.8% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 605337
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725
Gene

CFHR5 - atypical hemolytic uremic syndrome (aHUS)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

CFHR5 - atypical hemolytic uremic syndrome (aHUS)



€ 725

CFHR5 - atypical hemolytic uremic syndrome (aHUS)

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Atypical Hemolytic Uremic Syndrome (aHUS)
  • Conditions > Renal / Nephrological > Atypical Hemolytic Uremic Syndrome (aHUS)

This product is also part of the following panels:

  • WES Mendelian inherited disorders (97.5% **)
  • WES primary immunodeficiencies (97.5% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 608593
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725
Gene

DGKE - atypical hemolytic uremic syndrome (aHUS)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

DGKE - atypical hemolytic uremic syndrome (aHUS)



€ 725

DGKE - atypical hemolytic uremic syndrome (aHUS)

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Atypical Hemolytic Uremic Syndrome (aHUS)
  • Conditions > Renal / Nephrological > Atypical Hemolytic Uremic Syndrome (aHUS)

This product is also part of the following panels:

  • WES hemostatic/thrombotic disorders (98.3% **)
  • WES Mendelian inherited disorders (98.3% **)
  • WES metabolic disorders (98.3% **)
  • WES renal disorders (98.3% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 601440
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725
Gene

THBD - atypical hemolytic uremic syndrome (aHUS)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

THBD - atypical hemolytic uremic syndrome (aHUS)



€ 725

THBD - atypical hemolytic uremic syndrome (aHUS)

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Atypical Hemolytic Uremic Syndrome (aHUS)
  • Conditions > Renal / Nephrological > Atypical Hemolytic Uremic Syndrome (aHUS)

This product is also part of the following panels:

  • WES hemostatic/thrombotic disorders (100.0% **)
  • WES Mendelian inherited disorders (100.0% **)
  • WES primary immunodeficiencies (100.0% **)
  • WES renal disorders (100.0% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 188040
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725
MLPA

CFH operon - atypical hemolytic uremic syndrome (aHUS) (MLPA)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

CFH operon - atypical hemolytic uremic syndrome (aHUS) (MLPA)



€ 725

CFH operon - atypical hemolytic uremic syndrome (aHUS) (MLPA)

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Atypical Hemolytic Uremic Syndrome (aHUS)
  • Conditions > Renal / Nephrological > Atypical Hemolytic Uremic Syndrome (aHUS)

This product is often ordered in combination with:

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Deletion/duplication analysis (MLPA)

Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725